Purchase Order 36C25621P0072
- Not listed
- This firm fixed-price purchase order was awarded by the Veterans Integrated Service Network 16 (VISN 16), a civilian agency under the Department of Veterans Affairs (VA), to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $38,546.00, is for the procurement of MiSeq reagents, a specialized product used in Illumina's advanced sequencing instruments. The contract does not have a set-aside designation. Illumina holds several...
- This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $164,980.62 contract provides reagents to support whole genome sequencing using Illumina's MiSeq and NextSeq 2000 platforms, with a performance period through December 2023. The contract has no set-aside designation. Illumina is a well-established provider of sequencing solutions to federal agencies, having received...
- This is a firm fixed-price purchase order worth $91,039.93 awarded by the Department of Veterans Affairs (VA) to Illumina, Inc. for a MiSeq System. The award has no set-aside designation. Illumina, a manufacturer of genetic sequencing and analysis instruments, has a history of providing sequencing systems and related products and services to federal agencies like the NIH, CDC, USDA, and VA. The MiSeq System is likely being acquired to support the VA's genomic sequencing and analysis needs....
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 to Illumina, Inc., a manufacturer of sequencing and array-based analytical instruments and reagents. The contract is for the provision of an Illumina MiSeq System with a Silver Support Plan, with a potential value of $116,633.06 and a completion date of November 30, 2018. The contract does not have a set-aside designation. Illumina is a...
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments, to provide an NGS (Next Generation Sequencing) platform. The $162,825 contract has a completion date of September 30, 2021 and does not include any set-aside designation. Through previous prime federal contract awards, Illumina has supplied a range of its sequencing platforms, reagents,...
- This is a $33,773.36 firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The order is for the purchase of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated reagents and kits. This delivery order was not set aside for any small business categories. Illumina has previously provided sequencing goods and services to support research and diagnostics...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $16,976.00 contract is for the provision of Illumina reagents and does not have a set-aside designation. Illumina has previously provided a range of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies including the NIH, CDC,...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the provision of reagents. The contract has a potential value of $56,165.00 and a completion date of April 3, 2024. Illumina has previously been awarded prime federal contracts and subcontracts by agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, Department of...
- This federal contract award to Illumina, Inc., a manufacturer of sequencing and genomic analysis equipment and reagents, was issued by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 6. The $131,328.00 firm fixed price purchase order is for the delivery of Illumina assays and reagents to support genomic sequencing and analysis. This award does not have a set-aside designation. Illumina has a history of providing sequencing systems,...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Illumina, Inc. for the purchase of an Illumina MiSeq i100 Plus System. The total ceiling value of the award is $89,678.40 and the ultimate completion date is February 28, 2025. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. They have previously received prime federal contract awards from agencies like the National Institutes of...
This is a firm fixed price purchase order awarded to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents, by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16. The contract is for the provision of Illumina's MiSeq Reagent 600 Cycle product, with a potential value of $32,489.17. The contract has a completion date of March 22, 2024 and was awarded on October 1, 2020. There is no set-aside designation mentioned for this award. Illumina has a history of providing sequencing systems, reagents, and related services to various federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs, to support genomic research and diagnostics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($38k) | 4/11/24 | |
| P00001 | Supplemental Agreement for work within scope | $20.3k | 12/2/20 | |
| Not listed | Not listed | $50.4k | 10/1/20 |